|
|
Analysis of Drug Resistance Genes and Virulence Factors of Carbapenem-resistant Pseudomonas Aeruginosa Bloodstream Infection |
Liu Jing, Han Jing, Wu Xiaosha, Ma Yuqin |
Department of Laboratory Medicine,Anyang People's Hospital,Anyang 455000,China |
|
|
Abstract Objective To analyze the drug resistance genes and virulence factors of carbapenem-resistant pseudomonas aeruginosa(CR-PA)bloodstream infection(BSI). Methods A total of 156 inpatients with pseudomonas aeruginosa(PA)BSI were selected as the research subjects,51 strains of CR-PA were obtained after culturing their blood,urine,sputum and other samples.The antibacterial drug susceptibility test results of CR-PA and the positive detection rate of drug resistance genes and virulence genes were analyzed. Results Among the 51 CR-PA strains,the antibacterial drugs with the resistance rate≥50% were cefepime , meropenem , amikacin,cotrimoxazole , gentamicin and imipenem from high to low. Antibacterial drugs with the resistance rate≥50% were piperacillin+tazobactampyocyanin, ciprofloxacin and ticarcillin from high to low. Among them,piperacillin+tazobactampyocyanin was the antibacterial drug with the lowest resistance rate and the highest drug sensitivity rate.Among the 51 strains of CR-PA,the positive rate of resistance gene ant(2'')-I(58.82%)and virulence gene plcH(100.00%)were the highest.And the drug resistance genes with a positive rate over 50.00% were aprA(98.04%),exoS(92.16%),algD(82.35%),exoT(82.35%),and exoU(68.63%). Conclusions The drug resistance genes and virulence genes are widely distributed in CR-PA of BSI patients,and the clinical isolation rate of drug resistance gene ant(2'')-Ⅰ and virulence gene plcH is high.
|
Received: 18 August 2022
|
|
|
|
|
[1] 付玉冰,董爱英,汪亚斯,等.血流感染CRKP的临床特点及高毒力血清型分析[J].中国抗生素杂志,2019,44(9):1091-1095. [2] 邓秋婵,匡文斌,张肄鹏,等.NLRP3在巨噬细胞抗铜绿假单胞菌感染中的作用[J].广东医学,2019,40(3):321-328. [3] 宋皓月,黄凯峰,汤荣,等.2014-2017年上海市某医院铜绿假单胞菌不同耐药性菌株的临床分布[J].中国感染控制杂志,2019,18(12):1093-1098. [4] 彭少华,李艳李,从荣,等.细菌感染实验诊断与分析[M].北京:人民军医出版社,2006:45-49. [5] 周云,李享宸,宋光彩,等.血液病患者合并血流感染74例临床分析[J].中国感染与化疗杂志,2021,21(1):21-26. [6] 高云,王洁,丁红梓,等.抗菌药物使用频度与铜绿假单胞菌耐药性的相关性[J].西北药学杂志,2021,36(3):504-507. [7] 张新颖,韩颖,王雅妹,等.铜绿假单胞菌耐药性与抗菌药物使用强度相关性分析[J].河北大学学报(自然科学版),2021,41(2):188-194. [8] 林秀娟,朱健强,周勇.神经外科耐碳青霉烯类铜绿假单胞菌肺部感染的危险因素分析[J].广州医科大学学报,2021,49(2):1-5. [9] Paz-Zarza VM,Mangwani-Mordani S,Martínez-Maldonado A,et al.Pseudomonas aeruginosa:patogenicidad y resistenciaantimicrobianaen la infecciónurinaria Pseudomonas aeruginosa:Pathogenicity and antimicrobial resistance in urinary tract infection[J].Rev ChilenaInfectolm 2019,36(2):180-189. [10] 袁利,徐羽中,程明刚,等.耐碳青霉烯类铜绿假单胞菌耐药现状及整合子耐药基因分析[J].中国医学装备,2018,15(4):80-83. [11] 张鸿,胥志敏,陈炜,等.PA1864基因敲除对铜绿假单胞菌毒力及致病性的影响[J].中国感染控制杂志,2019,18(6):465-473. [12] Azam MW,Khan AU.Updates on the pathogenicity status of Pseudomonas aeruginosa[J].Drug Discov Today,2019,24(1):350-359. [13] 徐燕,王彦,张卉,等.获得性肺炎老年患者铜绿假单胞菌分离株毒力基因及耐药基因研究[J].中华临床感染病杂志,2019,12(1):64-69. |
[1] |
. [J]. journal1, 2023, 43(2): 143-144. |
|
|
|
|